Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes (COLCOT-T2D)

NCT05633810 is registered in ClinicalTrials.gov with Montreal Heart Institute as lead sponsor.

NCT NCT05633810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05633810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes (COLCOT-T2D)
Lead sponsor
Montreal Heart Institute
Phase
Phase 3
Overall status
Recruiting
Start date
December 21, 2022
Completion date
December 31, 2027
Enrollment
10,000 (estimated)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, diabete type 2